Pretax income is the income that a company earns before paying income taxes. Vicapsys Life Sciences's pretax income for the
three
months ended in Sep. 2023 was $-0.24 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Sep. 2023 was $-1.08 Mil.
Vicapsys Life Sciences's pretax margin was %.
During the past 6 years, Vicapsys Life Sciences's highest Pretax Margin was -21.45%. The lowest was -35.84%. And the median was -28.65%.
Vicapsys Life Sciences Pre-Tax Income Historical Data
The historical data trend for Vicapsys Life Sciences's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Vicapsys Life Sciences's Pre-Tax Income
For the Biotechnology subindustry, Vicapsys Life Sciences's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vicapsys Life Sciences's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Vicapsys Life Sciences's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Vicapsys Life Sciences's Pre-Tax Income falls into.
Vicapsys Life Sciences Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Vicapsys Life Sciences's Pretax Income for the fiscal year that ended in Dec. 2022 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.08 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vicapsys Life Sciences (OTCPK:VICP) Pre-Tax Income Explanation
Vicapsys Life Sciences's Pretax Margin for the quarter that ended in Sep. 2023 is calculated as
During the past 6 years, Vicapsys Life Sciences's highest Pretax Margin was -21.45%. The lowest was -35.84%. And the median was -28.65%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vicapsys Life Sciences Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Vicapsys Life Sciences's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Vicapsys Life Sciences (Vicapsys Life Sciences) Business Description
Vicapsys Life Sciences Inc is a biotech company that is engaged in commercializing implantable medical products that incorporate VICAPSYN, inducing a zone of immuno-protection around devices and cells implanted in the human body. The product name VICAPSYN is the company's line of proprietary product candidates that is applied to transplantation therapies and related stem-cell applications in the transplantation field.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VICP has been successfully added to your 